The Netherlands Journal of Medicine

Abscess of the spleen
pp. 11+12-14(4)
Authors: Methling D.; Jaschinski W.; Narcisi B.; Sternberg R.W.; Cacchione D.A.; Paulson B.; Kineke G.C.; Drake D.E.; Peters F.P.J.; Hochstenbag M.M.H.; Van Der Ent F.W.C.; Erdkamp F.L.G.

Lactase: gene expression, localization, and function.
pp. 1-1(1)
Authors: Rings E.H.H.M.; van Beers E.H.; Dekker J.; Buller H.A.

Detection of K-ras mutations in faeces of patients with colorectal tumours, using PCR.
pp. 1-1(1)
Authors: Koornstra J.J.; Ulvik A.; Rokke O.; Halvorsen J.F.; Haug K.; Ogreid D.

The clinical presentation of reflux oesophagitis, hiatal hernia, Barrett's oesophagus and reflux-like dyspepsia: a prospective clinical and endoscopic study.
pp. 2-2(1)
Authors: Werdmuller B.; van der Putten A.B.M.M.; Loffeld R.J.L.F.

Lansoprazole (30 mg) is more effective than high-dose ranitidine (2 x 300 mg) in achieving endoscopic healing and relief of symptoms in moderate to severe reflux oesophagitis (Grade II and III): a Dutch multi-centre trial.
pp. 2-2(1)
Authors: Hazenberg B.P.; Tan T.G.; Snel P.; Meijer W.W.; Janse J.B.M.J.

The initial and chronic acid inhibition by lansoprazole and omeprazole in relation to meal administration.
pp. 2-3(2)
Authors: Brummer R.-J.M.; Geerling B.J.; Stockbrugger R.W.

Upper gastrointestinal bleeding survey in Greater Amsterdam.
pp. 3-3(1)
Authors: Vreeburg E.M.; de Castro C.; Snel P.; de Bruijne J.W.; Bartelsman J.W.F.M.; Tytgat G.N.J.

The effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: a randomized double-blind placebo-controlled multicentre study.
pp. 3-4(2)
Authors: de Muckadell O.B.S.; Havelund T.; Harling H.; Boesby S.; Snel P.; Vreeburg E.M.; Eriksson S.; Fernstrom P.; Hasselgren G.

Is the international prognostic index (IPI) for aggressive nodal lymphomas also useful for gastric MALT lymphoma? - Assessment of prognostic factors.
pp. 4-4(1)
Authors: Boot H.; Taal B.G.; de Jong D.; Hart A.A.M.; Van Heerde P.

Primary non-Hodgkin's lymphoma of the stomach: the MALT concept in relation to endoscopic diagnosis and prognosis.
pp. 4-5(2)
Authors: Taal B.G.; Boot H.; de Jong D.; van Heerde P.; Hart A.A.M.; Burgers J.M.V.

Intraluminal gastric and duodenal pH in chronic pancreatitis.
pp. 5-5(1)
Authors: Eddes E.H.; Geus W.P.; Gielkens H.A.J.; Lamers C.B.H.W.; Masclee A.A.M.

The effect of sennosides on colonic mucosal histology and quality and tolerance of bowel preparation.
pp. 5-5(1)
Authors: van Gorkom B.A.P.; Karrenbeld A.; Limburg A.J.; Kleibeuker J.H.

Cyclosporine in treatment of refractory coeliac disease.
pp. 5-6(2)
Authors: Wahab P.J.; Meijer J.W.R.; Uil J.; Mulder C.J.J.

The ''Dutch Inflammatory Bowel Disease Questionnaire'': validation and usefulness in clinical trials.
pp. 6-6(1)
Authors: Russel M.G.; Brandon S.; Pastoor C.; Engels L.; Rijken J.; Stockbrugger R.W.

Smoking influences quality of life in inflammatory bowel disease.
pp. 6-6(1)
Authors: Russel M.G.; van Deursen C.; Nieman F.; Stockbrugger R.W.

Differences in the clinical course of Crohn's disease between children and adults.
pp. 7-7(1)
Authors: Wagtmans M.J.; van Hogezand R.A.; Verspaget H.W.; Lamers C.B.H.W.; Mearin M.L.

Pharmacokinetics of budesonide-controlled ileal release capsules in active Crohn's disease.
pp. 7-7(1)
Authors: Naber A.H.J.; Olaison G.; Smedh K.; Jansen J.B.M.J.; Sjodahl R.

Prevalence and characterization of anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel diseases.
pp. 7-8(2)
Authors: Roozendaal C.; Broekroelofs J.; Horst G.; Kleibeuker J.H.; Nelis G.F.; Limburg P.C.; Kallenberg C.G.M.

Complications in the use of the subcutaneous tunnelled intratracheal oxygen catheter
pp. 8-10(3)
Authors: Sanders T.M.; Garvine R.W.; in 't Veen J.C.C.M.; Stolk J.; Dijkman J.H.

Effect of meal ingestion on azygos and portal venous blood flow in healthy subjects non-invasively measured with magnetic resonance.
pp. 8-8(1)
Authors: Land N.; van Hoek B.; Wasser M.; Masclee A.A.M.; Kool L.S.; Lamers C.B.H.W.

Which patients with liver cirrhosis and hyperammonaemia develop encephalopathy?
pp. 8-8(1)
Authors: Hartmann I.J.C.; Quero J.C.; Meulstee J.; Hop W.C.J.; Schalm S.W.

Similarity in mutations of the ferrochelatase gene between Dutch and Japanese patients with erythropoietic protoporphyria.
pp. 8-9(2)
Authors: de Rooij F.W.M.; de Baar-Heesakkers E.; Minderman-Voortman G.J.; Wilson J.H.P.

The timing of transplantation for cholestatic liver disease.
pp. 9-9(1)
Authors: Liver Transplantation Group; de Rave S.

Late effects of liver transplantation on bone mass.
pp. 9-9(1)
Authors: van Bergeijk J.D.; de Rave S.; de Man R.A.; IJzermans J.N.M.; Tilanus H.W.; Metselaar H.J.

The effect of preoperative biliary drainage on the abnormal lipoprotein spectrum in obstructive jaundice: a protective effect of drainage?
pp. 9-10(2)
Authors: Kimmings A.N.; van Deventer S.J.H.; Obertop H.; Rauws E.A.J.; Gouma D.J.

Percutaneous stenting in bile duct obstruction.
pp. 10-10(1)
Authors: Wahab P.J.; Wiersma T.J.; ten Haken G.B.; den Hartog G.; Mulder C.J.J.

Hepatitis B transmission among heart transplant recipients: an underestimated risk?
pp. 10-11(2)
Authors: de Man R.A.; Schalm S.W.; Balk A.H.H.M.; Vos M.C.; Rothbarth P.H.; Mouton J.W.; Niesters H.G.M.; Osterhaus A.D.M.E.; Verbrugh H.A.

Analysis of an epidemic hepatitis B infection among heart transplant recipients by automated sequence analysis.
pp. 11-11(1)
Authors: Niesters H.G.M.; Vos M.C.; Rothbarth P.; Mouton J.W.; Balk A.H.M.M.; Verbrugh H.A.; de Man R.A.; Schalm S.W.; Osterhaus A.D.M.E.

Ursodeoxycholic acid (UDCA) reduces protein levels and their nucleation-promoting activity in gallbladder bile of cholesterol stone patients.
pp. 11-11(1)
Authors: van Erpecum K.J.; Portincasa P.; Eckhardt E.; van Berge-Henegouwen G.P.; Groen A.K.

Should Helicobacter pylori be considered as a risk factor for hepatic encephalopathy in patients with liver cirrhosis?
pp. 11-12(2)
Authors: Quero J.C.; Hartmann I.J.C.; de Rooij F.W.M.; Wilson J.H.P.; Schalm S.W.

Clinical presentation and diagnostic features of patients with hepatocellular carcinoma.
pp. 12-12(1)
Authors: Romijn M.; Bac D.J.; Lameris J.S.; Tilanus H.W.; Schalm S.W.; IJzermans J.N.M.

Persistent unconjugated hyperbilirubinaemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyl-transferase gene promoter sequence in the donor liver.
pp. 12-12(1)
Authors: Jansen P.L.M.; Haagsma E.B.; Lems S.P.M.; Gouw A.S.H.; Slooff M.J.H.; Trivin F.; Bakker C.; Bosma P.J.

Reduced bilirubin UDP-glucuronosyltransferase expression in Gilbert syndrome is caused by a sequence abnormality in the promoter region.
pp. 13-13(1)
Authors: Bosma P.J.; Bakker C.; de Boer A.; Tytgat G.N.J.; Elferink R.P.J.O.; Jansen P.L.M.; Lindhout D.; Oostra B.A.; Chowdhury N.R.; Chowdhury J.R.

Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine is associated with a decrease in HBV-DNA by PCR.
pp. 13-13(1)
Authors: Honkoop P.; de Man R.A.; Zondervan P.E.; Niesters H.G.M.; Schalm S.W.

Performance of three commercially available ELISAs in detecting Helicobacter pylori infection when compared to biopsy-dependent diagnosis.
pp. 13-13(1)
Authors: van de Wouw B.A.M.; de Boer W.A.; Jansz A.R.

Treatment of H. pylori infection with low- or high-dose omeprazole combined with amoxicillin and the effect of early retreatment: a prospective randomized double-blind study.
pp. 13-14(2)
Authors: van der Hulst R.W.M.; Weel J.F.L.; Verheul S.B.; Keller J.J.; Kate F.J.W.T.; van der Ende A.; Rauws E.A.J.; Dankert J.; Tytgat G.N.J.

No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori.
pp. 14-14(1)
Authors: A. C.I.T.L.T.; den Hartog G.; Meijer J.W.R.; Thies J.E.; De Vries R.A.; Mulder C.J.J.

Long-term follow-up after successful eradication of Helicobacter pylori with 1 or 2 weeks of quadruple therapy.
pp. 14-15(2)
Authors: Hermsen H.W.E.M.; de Boer W.A.; Driessen W.M.M.; Geuskens L.M.; van de Wouw B.A.M.; Jansen J.B.M.J.

Listeria monocytogenes endocarditis in a patient with an aortic prosthetic valve
pp. 15-17(3)
Authors: Aller R.C.; Blair N.E.; Xia Q.; Rude P.D.; Cabezas M.C.; Cramer M.J.; de Jongh B.M.; de Maat C.E.M.

Only 4 days of quadruple therapy can effectively cure Helicobacter pylori infection.
pp. 15-15(1)
Authors: de Boer W.A.; Driessen W.M.M.

Effects of eradicating H. pylori on symptoms in non-ulcer dyspepsia patients.
pp. 15-15(1)
Authors: Verhulst M.L.; Hopman W.P.M.; Jansen J.B.M.J.

Helicobacter pylori and non-Helicobacter pylori bacterial flora before and after eradication therapy for Helicobacter pylori
pp. 15-16(2)
Authors: Jonkers D.; Houben P.; de Bruine A.; Stobberingh E.; Stockbrugger R.

Helicobacter pylori in gastric MALT lymphoma.
pp. 16-16(1)
Authors: Gisbertz I.; Jonkers D.; Arends J.W.; Stockbrugger R.; Schouten H.C.

cagA status of Helicobacter pylori in gastric MALT lymphoma.
pp. 16-16(1)
Authors: de Jong D.; Boot H.; Taal B.G.; van Dijk W.; Kuipers E.; Pals G.

Helicobacter pylori eradication and gastric MALT lymphoma -- early results.
pp. 16-17(2)
Authors: Boot H.; de Jong D.; van Heerde P.; Burgers J.V.M.; Taal B.G.

Gastric mucosal plasminogen activators in Helicobacter pylori infection.
pp. 17-17(1)
Authors: Gotz J.M.; Vergouwe Y.; Verspaget H.W.; Heerding M.M.; Sier C.F.M.; Lamers C.B.H.W.; Veenendaal R.A.

Tissue levels of matrix metalloproteinases 2 and 9 are related to the overall survival of patients with gastric cancer.
pp. 17-18(2)
Authors: Ganesh S.; Sier C.F.M.; Heerding M.M.; Griffioen G.; Hanemaaijer R.; van Krieken J.H.J.M.; Lamers C.B.H.W.; Verspaget H.W.

Spinal epidural abscess due to Aspergillus infection of the vertebrae: report of 3 cases
pp. 18-23(6)
Authors: DeMaster D.J.; Smith W.O.; Nelson D.M.; Aller J.Y.; Dubbeld P.; van Oostenbrugge R.J.; Twijnstra A.; Schouten H.C.

Bombesin infusion as a test to study lower oesophageal sphincter capacity.
pp. 18-18(1)
Authors: Straathof J.W.A.; Masclee A.A.M.; Gielkens H.A.J.; Lamers C.B.H.W.

In vitro effect of budesonide, prednisolone, cortisol, and ACTH on peripheral blood NK cell activity of Crohn's disease patients and controls.
pp. 18-18(1)
Authors: van Ierssel A.J.H.M.; Verspaget H.W.; Mieremet-Ooms M.A.C.; van der Zon J.M.; van Hogezand R.A.; Lamers C.B.H.W.

Tumour necrosis factor-alpha concentrations in whole gut lavage fluid do not represent disease activity in inflammatory bowel disease.
pp. 18-19(2)
Authors: Krumm P.J.J.M.; van Dijk A.P.M.; Tak C.J.A.M.; Zijlstra F.J.; van Blankenstein M.; Wilson J.H.P.

Somatostatin induces satiety and reduces food intake in lean healthy volunteers.
pp. 19-19(1)
Authors: Aarts S.; Straathof J.W.; Langius J.; Gielkens H.A.J.; Lamers C.B.H.W.; Masclee A.A.M.

Hyperglycaemia affects proximal gastric motor and sensor function during intestinal nutrient infusion.
pp. 19-19(1)
Authors: Hebbard G.S.; Samsom M.; Sun W.M.; Dent J.; Horowitz M.

Effect of lansoprazole on steatorrhoea and nutritional parameters in children with cystic fibrosis (CF).
pp. 19-20(2)
Authors: Tran T.M.D.; Van den Neucker A.; Hendriks H.; Heidendal G.; Forget P.P.

Twenty years of childhood coeliac disease in the Netherlands: clinical presentation.
pp. 20-20(1)
Authors: George E.K.; van der Velde E.A.; Franken H.C.M.; Houwen R.H.J.; Bouquet J.; Gijsbers C.F.M.; Hirasing R.A.; Mearin M.L.

Energy intake and energy expenditure in patients on home parenteral nutrition.
pp. 20-21(2)
Authors: Naber A.H.J.; Renckens M.; Vissenberg A.; Lamers R.; Bardoel E.A.G.; Katan M.B.; Jansen J.B.M.J.

A new method to monitor the depletion of liver glycogen using a naturally ¹³C-enriched carbohydrate diet and ¹³CO₂ breath testing.
pp. 21-21(1)
Authors: Tanis A.A.; van den Berg J.W.O.; Rietveld T.; Wattimena J.L.D.; Swart G.R.

Cancer cachexia predicted by altered hepatic glucose metabolism as detected by ³¹P magnetic resonance spectroscopy (MRS).
pp. 21-22(2)
Authors: Dagnelie P.C.; Sijens P.E.; van den Berg J.W.O.; Swart G.R.; Wilson J.H.P.; Oudkerk M.

Pancreatic elastase-1 in faeces: a novel sensitive and specific test for pancreatic function?
pp. 22-22(1)
Authors: Masclee A.A.M.; Biemond I.; Gielkens H.A.J.; Vecht J.; Lamers C.B.H.W.

Differences in antroduodenal motility pattern and small bowel transit time between pre- and post-pyloric tube feeding.
pp. 22-22(1)
Authors: Ledeboer M.; Masclee A.A.M.; Coenraad M.; Vecht J.; Biemond I.; Lamers C.B.H.W.

Laparoscopic approach in antireflux surgery does not prevent vagal nerve damage.
pp. 23-23(1)
Authors: Masclee A.A.M.; Ringers J.; Terpstra O.T.; Bemelman W.; Lamers C.B.H.W.

Long-term immunity to hepatitis B infection after vaccination with recombinant hepatitis B vaccine.
pp. 23-23(1)
Authors: Boland G.J.; de Gast G.C.; Italiaander E.; van der Reijden J.; van Hattum J.

Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): incidence, clinical course and risk factors.
pp. 23-24(2)
Authors: Sevinc I.; Groeneweg M.; Lameris J.S.; Pieterman H.; Schalm S.W.; de Rave S.; van Buuren H.R.

Diabetes mellitus and traffic incidents
pp. 24-26+27(3)
Authors: Chan O.Y.C.; Edwards M.; Brown B.; Matsusaka S.; Masuda H.; Veneman T.F.

Primary gastric B-cell lymphoma and Helicobacter pylori.
pp. 24-24(1)
Author: Isaacson P.G.

A prospective randomized study of partially covered versus non-covered Wallstents.
pp. 24-25(2)
Authors: Smits M.E.; Rauws E.A.J.; Groen A.K.; Tytgat G.N.J.; Huibregtse K.

Potential hazards and artifacts of self-expandable oesophageal stents in magnetic resonance imaging (MRI).
pp. 25-25(1)
Authors: Taal B.G.; Muller S.; Boot H.; Koops W.

Oesophageal granular cell tumours in the Netherlands, 1987-1992: a survey.
pp. 25-25(1)
Authors: Voskuil J.H.; van Dijk C.M.; Wagenaar S.S.; van Vliet A.C.M.; Timmer R.; van Hees P.A.M.

Dieulafoy's disease: endosonographic detection and endosonography-guided treatment.
pp. 25-26(2)
Authors: Fockens P.; Meenan J.; van Dullemen H.M.; Tytgat G.N.J.

Needle knife papillotomy for endoscopic cholangiography and sphincterotomy.
pp. 26-26(1)
Authors: van Essen H.A.; Schelfhout L.J.D.M.; Ritsema G.H.

Flexible endoscopic treatment of Zenker's diverticulum (n = 30).
pp. 26-26(1)
Authors: Mulder C.J.J.; Wahab P.J.; den Hartog G.; Thies J.E.

Pilot experiences with argon plasma coagulation in gastrointestinal endoscopy.
pp. 26-27(2)
Authors: Wahab P.J.; Mulder C.J.J.; den Hartog G.; Thies J.E.; Uil J.J.

Accuracy of diagnostic procedures in acute upper gastrointestinal bleeding.
pp. 27-27(1)
Authors: Vreeburg E.M.; Snel P.; de Bruijne J.W.; Bartelsman J.W.F.M.; Rauws E.A.J.; Tytgat G.N.J.

Have endoscopists finally achieved parity with radiologists?
pp. 27-28(2)
Authors: van Blankenstein M.; Siersema P.D.; Dees J.; Meulen J.v.d.; de Baat L.; van Boven G.J.; Ottes F.

Results of partial resections in segmental large bowel Crohn's disease.
pp. 28-28(1)
Authors: Verhage A.H.; Schouten W.R.

Measurement of colorectal transit time: the golden standard of evaluation in the approach to constipated patients?
pp. 28-28(1)
Authors: Mollen R.M.H.G.; Claassen A.; Kuijpers J.H.C.

Acute vasodilatation in early dumping syndrome.
pp. 28-29(2)
Authors: Vecht J.; Winter M.; P. C.; Lamers C.B.H.W.; Masclee A.A.M.

Guidelines for efficient peripheral blood progenitor cell collection
pp. 29-37(9)
Authors: Franklin R.R.; Sarr D.; Gueye M.; Sylla O.; Collignon R.; Mock N.; Van Hoef M.E.H.M.

Pain management in chronic pancreatitis.
pp. 29-29(1)
Authors: Slappendel R.; Verheijen R.; Crul B.J.P.; Jansen J.B.M.J.

Diagnostic laparoscopy and laparoscopic ultrasonography in preoperative staging of liver and proximal bile duct tumours.
pp. 29-30(2)
Authors: van Dijkum E.J.M.N.; de Wit L.T.; van Delden O.M.; Rauws E.J.A.; Gouma D.J.

The incidence of local recurrence after surgery for rectal carcinoma.
pp. 30-30(1)
Authors: Cornel E.B.; Schattenkerk M.E.

Laparoscopy for acute cholecystitis.
pp. 30-30(1)
Authors: van den Broek W.T.; Bijnen A.B.; de Ruiter P.

Function of the proximal stomach after Nissen fundoplication.
pp. 30-31(2)
Authors: Wijnhoven B.P.L.; Salet G.A.M.; Roelofs J.M.M.; Smout A.J.P.M.; Akkermans L.M.A.; Gooszen H.G.

Sexual and bladder dysfunction after total mesorectal excision (TME) followed by pouch-anal anastomosis.
pp. 31-31(1)
Authors: Slors J.F.M.; van Zuijlen P.P.M.; Taat C.W.; van Dijk J.G.

Development of atrophic gastritis after Nissen fundoplication.
pp. 31-31(1)
Authors: Kuipers E.J.; Lundell L.; Havu N.

Normal anal sphincter complex and fistula-in-ano: endoanal sonography versus endoanal MRI.
pp. 31-32(2)
Authors: Hussain S.M.; Stoker J.; Schouten W.R.; Lameris J.S.

Selective laparoscopy for possible acute appendicitis.
pp. 32-32(1)
Authors: van Eerten P.V.; Bijnen A.B.; de Ruiter P.

Tumour DNA content and cell proliferation (Ki-67) in distal bile duct carcinomas assessed in 33 subtotal pancreatoduodenectomy specimens.
pp. 32-33(2)
Authors: van Gulik T.M.; Umezawa A.; Koyama K.; Obertop H.; Gouma D.J.; Bosma A.; Offerhaus G.J.A.

Gene transfer into hepatocytes in vivo.
pp. 33-33(1)
Authors: Wilke M.; Timmers-Reker A.J.M.; Bijma A.; Scholte B.; Sinaasappel M.

The effect of recombinant BPI₂₁ on endotoxin-induced mortality in rats with bile duct ligation.
pp. 33-34(2)
Authors: Kimmings A.N.; van Deventer S.J.H.; Obertop H.; Gouma D.J.

Differential effects of nitric oxide synthase (NO) inhibitors on endotoxin-induced liver damage in rats.
pp. 34-34(1)
Authors: Vos T.A.; Jansen P.L.M.; Moshage H.; Havinga R.; Gouw A.S.H.; Kuipers F.

Apolipoprotein (Apo) E4 genotype is associated with increased risk of cholesterol (XOL) gallstone recurrence after shock-wave lithotripsy (ESWL).
pp. 34-34(1)
Authors: Portincasa P.; van Erpecum K.J.; van de Meeberg P.; Dallinga-Thie G.M.; de Bruin T.W.A.; van Berge-Henegouwen G.P.

Non-supparative cholangitis: differences in liver pathology between male and female mdr2 knockout mice.
pp. 34-35(2)
Authors: van Nieuwkerk C.M.J.; Ottenhoff R.; van Wijland M.; Tytgat G.N.J.; Offerhaus G.J.A.; Groen A.K.; Elferink R.P.J.O.

MUC2 in ulcerative colitis: a quantitative study.
pp. 35-35(1)
Authors: van der Wal J.-W.G.; Tytgat K.M.A.J.; Einerhand A.W.C.; Buller H.A.; Dekker J.

TNF genes are more important for the in vitro production of tumour necrossis factor alpha and lymphotoxin alpha than HLA-DR antigens. Relevance for inflammatory bowel disease.
pp. 35-36(2)
Authors: Bouma G.; Crusius J.B.A.; Meuwissen S.G.M.; Pena A.S.; Naipal A.; Giphart M.J.

Assessment of matrix metalloproteinases 2 and 9 in intestinal tissue of patients with inflammatory bowel diseases.
pp. 36-36(1)
Authors: Kubben F.J.G.M.; Heerding M.M.; Sier C.F.M.; van Hogezand R.A.; Wagtmans M.J.; Lamers C.B.H.W.; Verspaget H.W.

The anti-inflammatory effect of interleukin-10 in a rabbit model of colitis.
pp. 36-36(1)
Authors: Grool T.A.; van Dullemen H.; Meenan J.; Koster F.; Spaans J.; Tytgat G.N.J.; van Deventer S.J.H.

A cell line model of mucin biosynthesis in the human intestine.
pp. 36-37(2)
Authors: van Klinken B.J.W.; Oussoren E.; Weenink J.-J.; Buller H.A.; Dekker J.; Einerhand A.W.C.

Prevalence of gastro-oesophageal reflux disease (GORD) in the severely mentally handicapped.
pp. 37-37(1)
Authors: Bohmer C.J.M.; Niezen-de Boer M.C.; Klinkenberg-Knol E.C.; Nadorp J.H.S.M.; Meuwissen S.G.M.

Oesophageal reflux disease (GORD) in the severely mentally handicapped.
pp. 37-38(2)
Authors: Bohmer C.J.M.; Niezen-de Boer M.C.; Klinkenberg-Knol E.C.; Nadorp J.H.S.M.; Meuwissen S.G.M.

Research practice and data management
pp. 38-42+43(5)
Author: van Es G.A.

Are oesophageal motility and pH profiles in Barrett's oesophagus different from severe reflux oesophagitis?
pp. 38-38(1)
Authors: Coenraad M.; Ganesh S.; Straathof J.W.; Lamers C.B.H.W.; Masclee A.A.M.

Cerebral potentials evoked by oesophageal distention in functional dyspepsia.
pp. 38-39(2)
Authors: Salet G.A.M.; Roelofs J.M.M.; Weusten B.L.A.M.; Smout A.J.P.M.; Akkermans L.M.A.

The effect of meal temperature on the frequency of gastric myoelectrical activity.
pp. 39-39(1)
Authors: Verhagen M.A.M.T.; Luijk H.D.; Smout A.J.P.M.

Gallbladder (GB) emptying in vivo and contractility in vitro of gallstone patients on ursodeoxycholic acid (UDCA).
pp. 39-39(1)
Authors: van de Meeberg P.C.; Portincasa P.; van de Heijning B.J.M.; van Erpecum K.J.; Akkermans L.M.A.; van Berge Henegouwen G.

Childhood constipation: correlation between colonic transit times, symptomatology and outcome of treatment.
pp. 40-40(1)
Authors: van der Plas R.N.; Redekop W.K.; Benninga M.A.; Taminiau J.A.; Buller H.A.

Coagulation factor XIII in ulcerative colitis and Crohn's disease.
pp. 40-40(1)
Authors: Vrij A.A.; Rijken J.; van Wersch J.W.J.; Stockbruggerj R.W.

Regulators of plasminogen activator activity in tissue of patients with inflammatory bowel disease.
pp. 40-41(2)
Authors: Verspaget H.W.; Sier C.F.M.; Ganesh S.; Vloedgraven H.J.M.; Heerding M.M.; Griffioen G.; van Hogezand R.A.; Verheijen J.H.; Dooijewaard G.; Lamers C.B.H.W.

Lexipafant (BB882), a platelet-activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis.
pp. 41-41(1)
Authors: Grool T.A.; Meenan J.; Hommes D.; Dijkhuizen S.; ten Kate F.J.W.; Wood M.; Whittaker M.; Tytgat G.N.J.; van Deventer S.J.H.

Increased levels of gut homing IL4-secreting lymphocytes in inflammatory bowel disease.
pp. 41-41(1)
Authors: Grool T.A.; Spaans J.; Meenan J.; Lammers K.; Tytgat G.N.J.; van Deventer S.J.H.

IL-1ra gene polymorphism is associated with genetic susceptibility to ulcerative colitis and multiple sclerosis.
pp. 41-42(2)
Authors: Crusius J.B.A.; Polman C.H.; Bioque G.; Garcia A.; van Oosten B.W.; Dijkstra C.D.; Pena A.S.

IL-1/IL-1ra allelic cluster in genetic susceptibility to inflammatory bowel diseases.
pp. 42-42(1)
Authors: Bioque G.; Crusius J.B.A.; Koutroubakis I.; Bouma G.; Kostense P.J.; Meuwissen S.G.M.; Pena A.S.

Decreased production of chemokines in patients with Crohn's disease treated with anti-tumour necrosis factor therapy.
pp. 42-42(1)
Authors: Radema S.A.; van Dullemen H.M.; Tytgat G.N.J.; van Deventer S.J.H.